AMD reports great Q3 results, and what their acquisition of Xilinx means.
Let's review the charts and indicators.
As a special purpose acquisition company, RedBall Acquisition Corp. offers a new twist on investing in the business of sports.
The decline of the healthcare firm's stock offers the opportunity to sell out-of-the-money puts for an attractive premium.
Plus, there's talk of a possible combination of Advanced Micro Devices and Xilinx.
It's not the merits of the deal from a long-term perspective I want to trade. It's the beat down of the stock from above $13 to under $11.
The gauntlet has been thrown. Let the games begin.
Aggressive traders could go long BMY at two price levels.
Continue to hold previously recommended longs.
BMY's announced acquisition of MyoKardia for $13B comes less than a year after its purchase of Celgene.